Found 16 matching trials
Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes
PHASE4This trial is conducted in Europe. The aim of this trial is to investigate ...
Location
Novo Nordisk Investigational Site
Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes
PHASE4This trial is conducted in Europe. The aim of this trial investigate the th...
Location
Novo Nordisk Investigational Site
Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients
PHASE4The primary objective is to demonstrate the non-inferiority at six months o...
Location
Investigational Site Number 204
Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes
PHASE4This trial is conducted in Europe. The aim of this trial is to investigate ...
Location
Novo Nordisk Investigational Site
Mylan Insulin Aspart Study
PHASE3The aim of this phase III trial is to demonstrate the equivalence in the sa...
Location
Endocrinology Associates Montgomery
Post Marketing Surveillance Study of Biphasic Insulin Aspart 30
N/AThis study is conducted in Asia. The aim of this study is to review the saf...
Location
Multiple Locations
Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes
N/AThis study is conducted in Asia. The aim of this observational study is to ...
Location
Novo Nordisk Investigational Site
Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®
N/AThis study is conducted in Africa. The aim of this observational study is t...
Location
Multiple Locations
Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands
N/AThis study is conducted in Europe. The aim of this observational study is t...
Location
Novo Nordisk Investigational Site
Surveillance Study of NovoRapid® for New Drug Re-examination
N/AThis study is conducted in Asia. The aim of this study is to observe the sa...
Location
Novo Nordisk Investigational Site